CXCL12 and cancer: The CXCR4/CXCL12 axis is key in mediating drug resistance in TNBC via a multi-pronged mechanism of action, including pro-survival signalling, induction of EMT, maintenance of cancer stem cells, immune suppression, and metastatic dissemination [98].